阿托伐他汀诱导的难治性血小板减少症。

Atorvastatin-Induced Refractory Thrombocytopenia.

作者信息

Ghuman Jasmine, Manasewitsch Nicholas T, Ghuman Joban, Antwi-Amoabeng Daniel, Chahal Gurpreet

机构信息

Internal Medicine, University of Nevada, Reno School of Medicine, Reno, USA.

Internal Medicine, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, IND.

出版信息

Cureus. 2021 Jan 5;13(1):e12502. doi: 10.7759/cureus.12502.

DOI:10.7759/cureus.12502

PMID:33564510

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7861060/

Abstract

Drug-induced thrombocytopenia is rarely associated with statin medications. We describe the case of a 69-year-old woman who developed refractory thrombocytopenia following atorvastatin use. To our knowledge, this is the fourth reported case of atorvastatin-induced thrombocytopenia and the first reported case of atorvastatin-induced refractory thrombocytopenia. Additionally, we summarize the cases of statin-induced thrombocytopenia reported in the medical literature.

摘要

药物性血小板减少症很少与他汀类药物相关。我们描述了一名69岁女性在使用阿托伐他汀后出现难治性血小板减少症的病例。据我们所知，这是第四例报道的阿托伐他汀诱导的血小板减少症病例，也是首例报道的阿托伐他汀诱导的难治性血小板减少症病例。此外，我们总结了医学文献中报道的他汀类药物诱导的血小板减少症病例。